Doctor looking at a chart with her patient

Site and Patient-Centric Solutions

Our Solutions Clinical Development Site and Patient-centric Solutions
Select a Topic

Patients are the driving force behind the quest to develop better, safer and more targeted therapies. But patients are often treated as a data source, rather than the reason for research.

PPD provides a custom suite of tools and technologies — and direct input from thousands of patients — to design better trials, generate accurate data and achieve meaningful outcomes to support your product development program.

Three Considerations When Selecting a Sites & Patients Partner

Explore the infographic

Our drivers of study success

Four pillars underlie our strategic approach to selecting the right sites and enrolling the right patients:

Strategic feasibility
  • Leverages multiple sources of data to inform country and site recommendations, ensuring access to the right sites and patient populations most conducive to your protocol parameters
  • Performs analytics and predictive modeling to recommend optimal site-country mix and generate enrollment and timeline projections based on extensive data and experience
  • Cloud-based solutions through goBalto that streamline and automate selection and setup of the top-performing clinical research sites – more than 90,000 sites across 80+ countries to deliver significant savings and 30% quantifiable reduction in study startup cycle times
Clinical innovation
  • Robotic process automation (RPA) teaches talking bots to do repetitive, scripted tasks, such as manual quality control review of documents for critical errors to increase speed, efficiency and accuracy
  • Our Preclarus® technology platform gives you full transparency on your study’s progress by consolidating and standardizing data from multiple sources and presenting it via a client-facing dashboard for real-time, instant access to enrollment numbers, site performance and other critical parameters of study progress
Patient centricity
  • Gauges the patient and caregiver voices through protocol-specific surveys that identify potential issues with protocol design, patient recruitment and retention
  • Customizes patient concierge services to ease the burden of travel, scheduling, clinic visits and other logistical barriers to study participation
  • Engages with patient advocacy groups and patient advisers to guide your study design, planning and execution based on unique patient populations and protocol parameters 
  • Designs patient-friendly outreach campaigns that validate their experiences and reduce fear and uncertainty surrounding clinical trials
  • Partners with disease-specific patient communities to enhance awareness and improve access to clinical trials as possible treatment options
Site intelligence and activation
  • Secures country-level approvals, drives document collection/ethics committee and regulatory submissions, and negotiates global site contracts and site budgets
  • Partners with goBalto to enhance our site selection and facilitates secure document workflow 
  • Utilizes master agreements with sites and investigators to expedite startup process

Supporting every aspect of inclusive research

Overcoming barriers enables underrepresented patient populations to participate and engage throughout your clinical trial.

Learn more about ensuring patient diversity in clinical trials

AT PPD, patient feedback informs study planning and execution

Crohn’s patient

I may look fine, but chronic inflammation took my energy, my happiness, my friends, and left me with pain and shame.

Lupus patient

Being willing to ask for help is the hardest thing to learn for most of us who were so independent.

Fibromyalgia patient

You have energy one minute and you want to take on the world, but then it knocks you down. Some days you feel less than, broken and disposable.

PPD select sites

PPD continually nurtures its strategic partnerships with leading research sites and site networks worldwide, matching you with top performers that have demonstrated their speed, skill, efficiency and quality across hundreds of studies.

By choosing the right combination of AES and PPD Select sites for your study, we create the optimal platform for achieving success:

  • Greater access to qualified patients
  • Faster site activation
  • More patients enrolled from fewer sites
  • Fewer non-enrolling sites
  • Expedited trial completion